Fellowship · Louisville, KY
Sponsored by University of Louisville School of Medicine
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.
JAMA · 2024 · 690 citations · Harold Bays
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
The New England journal of medicine · 2023 · 716 citations · Harold Bays
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.
Journal of clinical lipidology · 2024 · 129 citations · Harold Bays
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation.
European journal of preventive cardiology · 2022 · 253 citations · Harold Bays
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial.
The New England journal of medicine · 2025 · 70 citations · Harold Bays
Ten things to know about ten cardiovascular disease risk factors.
American journal of preventive cardiology · 2021 · 179 citations · Harold Bays
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.
Obesity pillars · 2024 · 62 citations · Harold Bays
The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial.
Nature medicine · 2023 · 100 citations · Harold Bays